Differentiated Thyroid Cancer Drugs Market size is projected to grow from USD 6.1 billion in 2017, at a CAGR of 7.7% during the forecast period (2023-2029). The major drivers for this market are increasing incidence of thyroid cancer, rise in use of targeted therapies and technological advancements in drug discovery processes. On the other hand, […]
